Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
07/16/2009 | WO2009088125A1 A composition for sanitary supplies comprising mucosal immunoadjuvant and a preparation method thereof |
07/16/2009 | WO2009037539A3 Treatment of oestrogen dependant conditions in pre-menopausal women |
07/16/2009 | US20090182055 Fungicidal agent containing n-chlorotaurine and use thereof |
07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
07/16/2009 | US20090181975 Nebivolol in the treatment of sexual dysfunction |
07/16/2009 | US20090181055 Gallibacterium anatis isolate BIV-07990 deposited with ATCC under accession number ATCC No.PTA-3669; beta( beta )-haemolysis-positive, Gram-negative, oxidase-positive, catalase-positive, urease-negative, nitrate-positive and indole-negative; for treatment of respiratory diseases in poultry |
07/16/2009 | DE102008004100A1 New metallocene compounds are estrogen receptor modulators useful e.g. to treat preferably cancer, manic disorder, gynecomastia and/or female infertility, and to prevent mamma carcinoma |
07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
07/14/2009 | US7560131 High solubility composition with high isoflavone concentration and process of producing same |
07/14/2009 | CA2403321C Amide compounds and use thereof |
07/14/2009 | CA2254548C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
07/09/2009 | WO2009073586A8 Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels |
07/09/2009 | WO2009048590A3 Amino acid combinant omega oil aphrodisiac |
07/09/2009 | WO2008083192A8 Methods and formulations for improved bioavailability of antiprogestins |
07/09/2009 | US20090176889 Compounds for the treatment of metabolic disorders |
07/09/2009 | US20090176761 JNK Inhivitors for the Treatment of Endometriosis |
07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
07/08/2009 | EP2077267A1 Fused heterocyclic compound |
07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
07/08/2009 | CN100509782C NK* antagonists |
07/08/2009 | CN100509024C Combination of medication for treating chylous urine |
07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
07/07/2009 | US7557136 Pyrrolidine derivatives as oxytocin antagonists |
07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
07/02/2009 | WO2009079680A1 Use larch wood material for treating inflammation |
07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
07/02/2009 | US20090170825 Beta-lactamylalkanoic acids for treating premenstrual disorders |
07/02/2009 | US20090170774 Compositions and methods for enhancing fertility |
07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
07/02/2009 | US20090169641 Compressible particles |
07/02/2009 | US20090169634 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof |
07/02/2009 | US20090169584 Treatment of sleep disturbances |
07/02/2009 | DE102007053369A1 Use of a preparation containing a creatine-component and a further component of e.g. L-carnitine, acetyl-L-carnitine, arginine, glutathione, vitamin C and vitamin E, as a dietary supplement for improving the male fertility in vertebrates |
07/02/2009 | CA2747569A1 Use larch wood material for treating inflammation |
07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
07/01/2009 | EP2073825A2 Cinnamomi and poria composition and uses thereof |
07/01/2009 | EP2073814A2 Novel method of treatment of male sub-fertility |
07/01/2009 | EP2073798A2 Pharmaceutical nimodipine compositions |
07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
07/01/2009 | CN100506795C Indene ketone diindyl class compound, preparation method and medical use thereof |
07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
06/25/2009 | WO2009077186A1 Nonsteroidal progesterone receptor modulators |
06/25/2009 | WO2009049813A3 Process for producing a monophasic pharmaceutical product for limiting/reducing the risk of deep vein thrombosis united with oral contraception |
06/25/2009 | WO2009043577A3 Contraceptive 19-nor progesterones |
06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
06/25/2009 | US20090163454 Methods of Step-Down Hormone Treatment |
06/25/2009 | US20090162416 Polymer implants for timed release of drugs with particular emphasis on ovulation or spermiation of fish |
06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
06/24/2009 | CN100502913C Vitex trifolia extract and its preparing method and use |
06/24/2009 | CN100502899C Inspection method for Chinese medicinal composition for treating blood and qi depletion,irregular menstruation |
06/24/2009 | CN100502839C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
06/23/2009 | CA2492804C Novel inhibitors of kinases |
06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
06/18/2009 | WO2009075838A2 Treatment of menorrhagia with aromatase inhibitor |
06/18/2009 | WO2009075334A1 Uterine fibroid cell growth inhibitor, and prophylactic or therapeutic agent for uterine fibroid comprising the inhibitor |
06/18/2009 | WO2009074995A1 Taste masked chewable compositions of sildenafil citrate |
06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |